BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19395706)

  • 1. Proinsulin and the genetics of diabetes mellitus.
    Weiss MA
    J Biol Chem; 2009 Jul; 284(29):19159-63. PubMed ID: 19395706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological behaviors of mutant proinsulin contribute to the phenotypic spectrum of diabetes associated with insulin gene mutations.
    Wang H; Saint-Martin C; Xu J; Ding L; Wang R; Feng W; Liu M; Shu H; Fan Z; Haataja L; Arvan P; Bellanné-Chantelot C; Cui J; Huang Y
    Mol Cell Endocrinol; 2020 Dec; 518():111025. PubMed ID: 32916194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.
    Dhayalan B; Weiss MA
    Curr Diab Rep; 2022 Feb; 22(2):85-94. PubMed ID: 35119630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus due to the toxic misfolding of proinsulin variants.
    Weiss MA
    FEBS Lett; 2013 Jun; 587(13):1942-50. PubMed ID: 23669362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin misfolding and endoplasmic reticulum stress during the development and progression of diabetes.
    Sun J; Cui J; He Q; Chen Z; Arvan P; Liu M
    Mol Aspects Med; 2015 Apr; 42():105-18. PubMed ID: 25579745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Lessons From the Mutant Proinsulin Syndrome.
    Dhayalan B; Chatterjee D; Chen YS; Weiss MA
    Front Endocrinol (Lausanne); 2021; 12():754693. PubMed ID: 34659132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinsulin misfolding is an early event in the progression to type 2 diabetes.
    Arunagiri A; Haataja L; Pottekat A; Pamenan F; Kim S; Zeltser LM; Paton AW; Paton JC; Tsai B; Itkin-Ansari P; Kaufman RJ; Liu M; Arvan P
    Elife; 2019 Jun; 8():. PubMed ID: 31184302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brief perspective on insulin production.
    Steiner DF; Park SY; Støy J; Philipson LH; Bell GI
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():189-96. PubMed ID: 19817801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum oxidoreductin-1α (Ero1α) improves folding and secretion of mutant proinsulin and limits mutant proinsulin-induced endoplasmic reticulum stress.
    Wright J; Birk J; Haataja L; Liu M; Ramming T; Weiss MA; Appenzeller-Herzog C; Arvan P
    J Biol Chem; 2013 Oct; 288(43):31010-8. PubMed ID: 24022479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis, structure, and folding of the insulin precursor protein.
    Liu M; Weiss MA; Arunagiri A; Yong J; Rege N; Sun J; Haataja L; Kaufman RJ; Arvan P
    Diabetes Obes Metab; 2018 Sep; 20 Suppl 2(Suppl 2):28-50. PubMed ID: 30230185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct states of proinsulin misfolding in MIDY.
    Haataja L; Arunagiri A; Hassan A; Regan K; Tsai B; Dhayalan B; Weiss MA; Liu M; Arvan P
    Cell Mol Life Sci; 2021 Aug; 78(16):6017-6031. PubMed ID: 34245311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin entry and transit through the endoplasmic reticulum in pancreatic beta cells.
    Liu M; Wright J; Guo H; Xiong Y; Arvan P
    Vitam Horm; 2014; 95():35-62. PubMed ID: 24559913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical Correlation.
    Dhayalan B; Glidden MD; Zaykov AN; Chen YS; Yang Y; Phillips NB; Ismail-Beigi F; Jarosinski MA; DiMarchi RD; Weiss MA
    Front Endocrinol (Lausanne); 2022; 13():821069. PubMed ID: 35299972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide Model of the Mutant Proinsulin Syndrome. II. Nascent Structure and Biological Implications.
    Yang Y; Glidden MD; Dhayalan B; Zaykov AN; Chen YS; Wickramasinghe NP; DiMarchi RD; Weiss MA
    Front Endocrinol (Lausanne); 2022; 13():821091. PubMed ID: 35299958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes.
    Arunagiri A; Haataja L; Cunningham CN; Shrestha N; Tsai B; Qi L; Liu M; Arvan P
    Ann N Y Acad Sci; 2018 Apr; 1418(1):5-19. PubMed ID: 29377149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinsulin folding and trafficking defects trigger a common pathological disturbance of endoplasmic reticulum homeostasis.
    Arunagiri A; Alam M; Haataja L; Draz H; Alasad B; Samy P; Sadique N; Tong Y; Cai Y; Shakeri H; Fantuzzi F; Ibrahim H; Jang I; Sidarala V; Soleimanpour SA; Satin LS; Otonkoski T; Cnop M; Itkin-Ansari P; Kaufman RJ; Liu M; Arvan P
    Protein Sci; 2024 Apr; 33(4):e4949. PubMed ID: 38511500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport.
    Liu M; Haataja L; Wright J; Wickramasinghe NP; Hua QX; Phillips NF; Barbetti F; Weiss MA; Arvan P
    PLoS One; 2010 Oct; 5(10):e13333. PubMed ID: 20948967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide Mispairing During Proinsulin Folding in the Endoplasmic Reticulum.
    Haataja L; Manickam N; Soliman A; Tsai B; Liu M; Arvan P
    Diabetes; 2016 Apr; 65(4):1050-60. PubMed ID: 26822090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INS-gene mutations: from genetics and beta cell biology to clinical disease.
    Liu M; Sun J; Cui J; Chen W; Guo H; Barbetti F; Arvan P
    Mol Aspects Med; 2015 Apr; 42():3-18. PubMed ID: 25542748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus due to toxic misfolding of proinsulin variants.
    Dhayalan B; Chatterjee D; Chen YS; Weiss MA
    Mol Metab; 2021 Apr; ():101229. PubMed ID: 33823319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.